Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
Global Cancer or Tumor Profiling Market Size study, By Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry, other technologies), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer, other cancer), By Applications (Clinical Application, Research Applications) and Regional Forecasts 2019-2026.
US$ 3,950.00
... by 2025. Increasing number of breast cancer cases would supplement global Cancer or Tumor profiling market for the forecasted period. However, ... , the Cancer or Tumor Profiling market is segmented into technology, cancer type and application. The technology segment of global Cancer or Tumor Profiling market is ...
July 2019
200 pages
Global Cancer/Tumor Profiling Market Size study, by Technology (Immunoassays, Hybridization, Next Generation Sequencing, Mass Spectrometry and other technologies) Cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal cancer, melanoma cancer and other cancer) Applications (Clinical Application and Research Applications) and Regional Forecasts 2019-2026.
US$ 3,950.00
... – 2019 to 2026 Target Audience of the Global Cancer/Tumor Profiling Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
July 2019
200 pages
New Zealand Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: Volume and Sales Forecasts, Analysis of Major Suppliers, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 3,450.00
... tactics, and new products in R&D. Market Segmentation Analysis Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease ... MALDI-TOF-MS, Mini-Sequencing Strategic Recommendations New product development opportunities for blood typing, grouping and infectious disease NAT assays and ...
July 2019
400 pages
NT-proBNP Test Volume and Sales Forecasts, 2019-2023: US, Europe, Japan
US$ 750.00
This new report from VPGMarketResearch provides analysis of NT-proBNP testing, including test volume and sales forecasts by country. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA
July 2019